• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

MANNKIND CORPORATION

Notes

No. Proposition For Against Abstain
1

DIRECTOR J.S. Shannon, MD, MRCP

2

DIRECTOR M.E. Castagna, Pharm.D.

3

DIRECTOR Steven B. Binder

4

DIRECTOR Ronald J. Consiglio

5

DIRECTOR Michael A. Friedman, MD

6

DIRECTOR Jennifer Grancio

7

DIRECTOR Anthony Hooper

8

DIRECTOR Sabrina Kay, Ed.D.

9

DIRECTOR Christine Mundkur

10

To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKinds proxy statement for the Annual Meeting.

11

To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2026.